Prescriby

Cover Block

Field	Value
Name	Prescriby
Tagline	Digital platform improving prescription safety and monitoring to prevent opioid addiction
Headquarters	Reykjavik, Iceland (with Canadian operations)
Founded	2019
Stage	Seed
Business Model	SaaS
Industry	Healthtech
Technology Type	Software (Non-AI)
Geography	Western Europe / North America
Growth Profile	Venture Scale
Funding Label	Seed
Total Disclosed	~$2,100,000

Links

• LinkedIn: https://is.linkedin.com/company/prescriby

Summary and Signal

Prescriby is an Icelandic-Canadian healthtech company building a prescription management platform aimed at preventing opioid dependence at the point of prescribing [EU-Startups, April 2024]. Founded in 2019 by Kjartan Thorsson, the company addresses the opioid crisis in North America and tighter prescribing protocols in European health systems [ArcticStartup]. The product combines a treatment generator with a dashboard monitor to simplify clinical decision-making around addictive medications [Crunchbase]. In April 2024, the company closed a $2.1 million seed round led by Crowberry Capital [Northstack] [EU-Startups, April 2024]. Prescriby has established a tapering clinic in Maine, suggesting a hybrid software-and-service approach to early commercialization [Mainebiz].

Data Accuracy: GREEN -- Confirmed by EU-Startups, ArcticStartup, Northstack, and Crunchbase.

Taxonomy Snapshot

Axis	Value
Stage	Seed
Business Model	SaaS
Industry / Vertical	Healthtech (prescription safety, addiction prevention)
Technology Type	Software (Non-AI)
Geography	Iceland HQ, Canadian operations, US pilot footprint
Founding Team	Kjartan Thorsson (founder)
Funding	Seed, ~$2.1M disclosed

Company Overview

Prescriby was founded in 2019 and operates as an Icelandic-Canadian entity [PitchBook] [ArcticStartup]. The premise is that the most effective intervention point for opioid dependence is upstream of addiction: at the moment a clinician writes the prescription and during the tapering window that follows [EU-Startups, April 2024].

The April 2024 seed round of $2.1 million was led by Nordic firm Crowberry Capital [Northstack] [EU-Startups, April 2024]. Prescriby has set up a tapering clinic in Maine, indicating the company is testing a clinical service layer alongside its software product [Mainebiz].

Data Accuracy: GREEN -- Confirmed by EU-Startups, Northstack, ArcticStartup, PitchBook, and Mainebiz.

The Product and the Stack

Prescriby's product is built around two components: a treatment generator that helps clinicians construct tapering and prescribing plans for addictive medications, and a dashboard monitor that tracks patient progress and surfaces risk signals to the prescribing clinic [Crunchbase]. The company's LinkedIn page positions the product as "the first data driven treatment management platform for addictive medication" [LinkedIn]. The Maine tapering clinic suggests Prescriby is using a directly-operated clinical site to refine the protocol library and gather outcomes data [Mainebiz].

On the technology stack, Prescriby is classified as Software (Non-AI). The differentiation rests on clinical protocol design and prescriber workflow.

Data Accuracy: YELLOW -- Product descriptions corroborated across Crunchbase and LinkedIn, but specific feature depth and integration partners are not independently verified.

Market Research and Opportunity

Demand drivers include elevated opioid-related mortality in the United States and Canada, state and provincial prescription drug monitoring programs, and payer receptivity to tools that demonstrate reduced long-term opioid utilization [ArcticStartup]. European health systems are also increasingly concerned with addictive-medication oversight [EU-Startups, April 2024].

Sizing claim	Value
Seed round size	$2.1M
Founding year	2019

Data Accuracy: YELLOW -- Demand drivers corroborated across EU-Startups and ArcticStartup, but no third-party TAM figure is publicly cited.

The Competitive Field

Prescriby is positioned as a prevention-first tool in a category dominated by post-addiction treatment platforms and broad clinical decision support vendors. The competitive set breaks into three groups: addiction treatment platforms, clinical decision support modules inside EHR systems (Epic, Cerner), and prescription drug monitoring program software sold to state and provincial health authorities.

Prescriby has an edge in clinical specificity and the operational data it can generate from its Maine tapering clinic [Mainebiz].

Data Accuracy: YELLOW -- Competitive framing is analytical; no direct named competitor appears in the cited public record.

Opportunity

If Prescriby executes, the prize is becoming the default clinical workflow layer for prescribing and tapering addictive medications across North American and European primary care [EU-Startups, April 2024] [ArcticStartup].

Scenario	What happens	Catalyst	Why it's plausible
Settlement-funded state contract	A US state health agency adopts Prescriby as the prescribing-prevention tool	A reference deployment in Maine [Mainebiz]	Maine and other states are allocating settlement funds to prevention infrastructure
Nordic public-health rollout	A Nordic national health system standardizes on Prescriby	Crowberry-led syndicate opens doors to health authorities [EU-Startups, April 2024]	Investor base is regionally embedded
EHR integration partnership	Prescriby becomes the embedded tapering protocol inside regional EHR platforms	A commercial partnership	Avoiding direct competition with EHRs is the path most specialty clinical tools have taken

Data Accuracy: YELLOW -- Scenarios are analytical extrapolations from cited funding, clinic, and market evidence; outcome figures are scenario-based and not forecasts.